Fast-atom bombardment mass spectrometric study of sate foscarnet prodrugs and of a series of foscarnet-azt conjugates

Rapid Communications in Mass Spectrometry

Volumn 11, Issue 11, 1997, Pages 1212-1218

  Rozenski, Jef ^a   Meier, Chris ^b   Aubagnac, Jean Louis ^c   Astier, René ^d   Herdewijn, Piet ^a   Imbach, Jean Louis ^d   Gosselin, Gilles ^d  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITÉ DE MONTPELLIER   (France)

^d UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MASS SPECTROMETERS; MASS SPECTROMETRY;

COLLISION INDUCED DISSOCIATION; FAST ATOM BOMBARDMENT; FRAGMENTATIONS PATTERN; PRODRUGS; THIOESTERS;

NEGATIVE IONS;

EID: 0030790506     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0231(199707)11:11<1212::AID-RCM2>3.0.CO;2-Y     Document Type: Article

References (41)

1. D. Kinchington, C. Minshull and C. Drummond, Int. Antiviral News 4, 132 (1996).
2. C. Minshull, S. Goldthorpe and D. Kinchington, Int. Antiviral News 4, 76 (1996).
3. P. Furman, J. Fyfe, M. St. Clair, K. Weinhold, J. Rideout, G. Freeman, S. Nusinoff, S. Lehrman, D. Bolognesi, S. Broder, H. Mitsuya and D. Barry, Proc. Natl. Acad. Sci. USA 83, 8333 (1986).
4. P. Chrisp and S. P. Clissold, Drugs 41, 104 (1991).
5. C. V. Fletcher, A. C. Collier, F. S. Rhame, D. Bennett, M. F. Para, C. C. Beatty, C. E. Jones and H. H. Balfour Jr. Antimicrob. Agents Chemother. 38, 604 (1994).
6. A. J. Wagstaff and H. M. Bryson, Drugs 48, 199 (1994).
7. Studies of ocular complications of AIDS research group, in collaboration with the AIDS clinical trial group. N. Engl. J. Med. 326, 213 (1992).
8. J. O. Noren, E. Helgstrand, N. G. Johansson, A. Misiorny and G. Stening, J. Med. Chem. 26, 264 (1983).
9. M. M. Vaghefi, P. A. Mekernan and R. K. Robins, J. Med. Chem. 29, 1389 (1986).
10. H. Griengl, W. Hayden, G. Penn, E. De Clercq and B. Rosenwirth, J. Med. Chem. 31, 1831 (1988).
11. R. W. Lambert, J. A. Martin, G. J. Thomas, I. B. Duncan and M. J. Hall, J. Med. Chem. 32, 367 (1989).
12. R. P. Iyer, L. R. Phillips, J. A. Biddle, D. R. Thakker, W. Egan, S. Aoki and H. Mitsuya, Tetrahedron Lett. 30, 7141 (1989).
13. C. C. Neto, J. M. Steim, P. S. Sarin, D. K. Sun, N. N. Bhongle, R. K. Piratla and J. G. Turcotte, Biochem. Biophys. Res. Commun. 171, 458 (1990).
14. A. Rosowsky, J. Saha, F. Fazely, J. Koch and R. M. Ruprecht, Biochem. Biophys. Res. Commun. 172, 288 (1990).
15. J. Saha, R. M. Ruprecht and A. Rosowsky, Nucleosides & Nucleotides 10, 1465 (1991).
16. A.-S. Charvet, M. Camplo, P. Faury, J.-C. Graciet, N. Mourier, J.-C. Chermann and J.-L. Kraus, J. Med. Chem. 37, 2216 (1994).
17. I. Walker, D. Nicholls, W. J. Irwin and S. Freeman, Int. J. Pharm. 104, 157 (1994).
18. R. P. Iyer, J. H. Boal, L. R. Phillips, D. R. Thakker and W. Egan, J. Pharm. Sci. 83, 1269 (1994).
19. K. Y. Hostetler, G. D. Kini, J. R. Beadle, K. A. Aldern, M. F. Gardner, R. Border, R. Kumar, L. Barshak, C. N. Sridhar, C. J. Wheeler and D. D. Richman, Antiviral Res. 31, 59 (1996).
20. A. D. Briggs, M. Camplo, S. Freeman, J. Lundström and B. G. Pring, Tetrahedon 52, 14937 (1996).
21. E. S. Krol, J. M. Davis and G. R. J. Thatcher, J. Chem. Soc. Chem. Commun., 118 (1991).
22. A. G. Mitchell, D. Nicholls, I. Walker, W. J. Irwin and S. Freeman, J. Chem. Soc. Perkin Trans. 2, 1297 (1991).
23. A. G. Mitchell, D. Nicholls, W. J. Irwin and S. Freeman, J. Chem. Soc. Perkin Trans. 2, 1145 (1992).
24. E. S. Krol and G. R. J. Thatcher, J. Chem. Soc. Perkin Trans 2, 793 (1993).
25. G. Gosselin and J.-L. Imbach, Int. Antiviral News 1, 100 (1993).
26. C. Périgaud, G. Gosselin, I. Lefebvre, J.-L. Girardet, S. Benzaria, I. Barber and J.-L. Imbach, Bioorg. Med. Chem. Lett. 3, 2521 (1993).
27. G. Gosselin, J.-L. Girardet, C. Périgaud, S. Benzaria, I. Lefebvre, N. Schlienger and J.-L. Imbach, Acta Biochem. Polon. 43, 195 (1996).
28. C. Périgaud, J. L. Girardet, G. Gosselin and J.-L. Imbach, In Advances in Antiviral Drug Design, E. De Clercq (Ed.), JAI Press Inc. Greenwich, Connecticut, Vol. 2, p.147 (1996).
29. C. Périgaud, A.-M. Aubertin, S. Benzaria, H. Pelicano, J.-L. Girardet, G. Maury, G. Gosselin, A. Kirn and J.-L. Imbach, Biochem. Pharmacol. 48, 11 (1994).
30. J.-L. Girardet, C. Périgaud, A.-M. Aubertin, G. Gosselin, A. Kirn and J.-L. Imbach, Bioorg. Med. Chem. Lett. 5, 2981 (1995).
31. I. Lefebvre, C. Périgaud, A. Pompon, A.-M. Aubertin, J.-L. Girardet, A. Kirn, G. Gosselin and J.-L. Imbach, J. Med. Chem. 38, 3941 (1995).
32. S. Benzaria, H. Pelicano, R. Johnson, G. Maury, J.-L. Imbach, A.-M. Aubertin, G. Obert and G. Gosselin, J. Med. Chem. 39, 4958 (1996).
33. B. F. H. Eriksson and R. F. Schinazi, Antimicrob. Agents Chemother. 33, 663 (1989).
34. R. Koshida, S. Cox, J. Harmenberg, G. Gilljam and B. Wahren, Antimicrob. Agents Chemother. 33, 2083 (1989).
35. X.-B. Kong, Q.-Y. Zhu, R. Ruprecht, K. Watanabe, J. Zeidler, J. Gold, B. Polsky, D. Armstrong and T. C. Chou, Antimicrob. Agents Chemother. 35, 2003 (1991).
36. S. Palmer, H. Rasmussen, J. Harmenberg and S. Cox, Antiviral Chem. Chemother. 7, 14 (1996).
37. J. M. Peltier, R. W. Smith, D. B. Mac Lean and W. A. Szarek, Carboh. Res. 207, 1 (1990).
38. J.-L. Aubagnac, I. Gilles, G. Gosselin, C. Périgaud, P. Labataille and J.-L. Imbach. Rapid Commun. Mass Spectrom. 7, 704 (1993).
39. J.-L. Aubagnac, I. Gilles, R. Lazaro, R.-M. Claramunt, G. Gosselin, G. and J. Martinez, Rapid Commun. Mass Spectrom. 9, 509 (1995).
40. Z. P. Yao, Q. M. Zha and S. K. Zhao, J. Mass Spectrom 31, 955 (1996).
41. J.-L. Aubagnac, Rapid Commun. Mass Spectrom. 4, 114 (1990).